Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus
Year: 2014
Type: article
Abstract: Diabetes mellitus (DM) is a risk factor for cardiovascular disease (CVD) [ 1 ]. Both traditional and nontraditional molecules have been explored to explain the development of DM-related CVD. Molecules associated with the circulatory system, such as the natriuretic peptides, which are counterregulatory hormones involved in the regulation of volume homeostasis and cardiovascular remodeling, are an important clue for understanding the underlying mechanisms of DM-related CVD [ 2 ]. The plasma brain natriuretic peptide (BNP) level is thus a predictor of CVD events and death [ 3 ]. Additionally, the oxidative stress burden may in part explain the link between DM and CVD [ 4 ]. Although several markers are applicable, the diacron reactive oxygen metabolites (d-ROMs) test and malondialdehyde (MDA) are indicators of the global oxidative stress burden in a clinical setting [ 5 ], especially in patients with type 2 DM (T2DM) [ 6 , 7 ].
Source: Endocrine
Institutions: Jichi Medical University, University of Tsukuba
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,090
OpenAlex ID: W2083401002
